Septerna (SEPN) Change in Receivables (2023 - 2026)
Septerna (SEPN) recorded quarterly Change in Receivables of $486000.0 in Q1 2026, down 71.6% quarter-over-quarter from $1.7 million in Q4 2025, and up 515.19% on a YoY basis from $79000.0 in Q1 2025.
Septerna (SEPN) Change in Receivables (2023 - 2026) Analysis & Trends
Septerna's Change in Receivables history runs 4 years deep, the most recent figure standing at $486000.0 for Q1 2026.
- In Q1 2026, Change in Receivables rose 515.19% year-over-year to $486000.0; the TTM figure through Mar 2026 stood at $10.6 million (up 7612.06% YoY), while the FY2025 annual figure was $10.2 million, up 50825.0% from the prior year.
- Change in Receivables was $486000.0 for Q1 2026 at Septerna, down from $1.7 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $8.5 million in Q3 2025 to a low of -$190000.0 in Q2 2024.
- Historically, Change in Receivables has averaged $1.1 million across 4 years, with a median of $98500.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Change in Receivables slumped 133.9% in 2024, then surged 84840.0% in 2025.
- A 4-year view of Change in Receivables shows it stood at $118000.0 in 2023, then plunged by 133.9% to -$40000.0 in 2024, then soared by 4377.5% to $1.7 million in 2025, then sank by 71.6% to $486000.0 in 2026.
- The last three Change in Receivables figures came in at $486000.0 (Q1 2026), $1.7 million (Q4 2025), and $8.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | 486,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 486,000.00 |
| Mar 31, 2026 | 486,000.00 |
| Dec 31, 2025 | 1.71 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | 8.49 Mn |
| Sep 30, 2025 | 8.49 Mn |
| Jun 30, 2025 | -99,000.00 |
| Jun 30, 2025 | -99,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | -190,000.00 |
| Jun 30, 2024 | -190,000.00 |
| Mar 31, 2024 | 240,000.00 |
| Mar 31, 2024 | 240,000.00 |
| Dec 31, 2023 | 118,000.00 |
| Dec 31, 2023 | 118,000.00 |